000			01475 a2200397 4500
005			20250515144818.0
264		0	_c20090810
008			200908s 0 0 eng d
022			_a1532-866X
024	7		_a10.1016/j.semarthrit.2008.08.006 _2doi
040			_aNLM _beng _cNLM
100	1		_aTerkeltaub, Robert A
245	0	0	_aColchicine update: 2008. _h[electronic resource]
260			_bSeminars in arthritis and rheumatism _cJun 2009
300			_a411-9 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aATP Binding Cassette Transporter, Subfamily B
650	0	4	_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xdrug effects
650	0	4	_aAdministration, Oral
650	0	4	_aCarrier Proteins _xdrug effects
650	0	4	_aColchicine _xpharmacokinetics
650	0	4	_aContraindications
650	0	4	_aCytochrome P-450 CYP3A _xdrug effects
650	0	4	_aCytoskeletal Proteins _xdrug effects
650	0	4	_aDrug Interactions
650	0	4	_aGout Suppressants _xpharmacokinetics
650	0	4	_aHumans
650	0	4	_aInjections, Intravenous
650	0	4	_aMEDLINE
650	0	4	_aNLR Family, Pyrin Domain-Containing 3 Protein
650	0	4	_aPericarditis _xdrug therapy
650	0	4	_aPractice Guidelines as Topic
650	0	4	_aPyrin
773	0		_tSeminars in arthritis and rheumatism _gvol. 38 _gno. 6 _gp. 411-9
856	4	0	_uhttps://doi.org/10.1016/j.semarthrit.2008.08.006 _zAvailable from publisher's website
999			_c18435801 _d18435801